Key facts
- MedevPlus’s last known valuation is $4.1M (Mar 2025).
- It has raised $310K; the latest was Later Stage VC ($270K) in Mar 2025.
- Notable investors include BIRAC, Sarthy Venture Investment Partners, BITS BioCyTiH Foundation, IKP Knowledge Park, NASSCOM DeepTech Club — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for MedevPlus
- ·The full record, as it builds
Funding rounds
No funding rounds for MedevPlus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MedevPlus
Developer of medical devices designed to solve social health care issues. The company's products are spread across animal scanning, oncology, pharmaceutical, industrial, and other domains, enabling healthcare professionals to identify diseases in early stages with accuracy.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 2018
- Employees
- 24
- Website
- medevplus.com/
- Ownership
- Privately Held (backing)
MedevPlus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedevPlus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedevPlus in its N-PORT filings yet. We sweep new filings monthly.